Skip to content

Medical Summary

What is HHT?


HHT is a hereditary bleeding disorder (meaning it is passed down through generations) that is characterized by abnormal blood vessel formation resulting in telangiectasia and arteriovenous malformations (AVMs). A person with HHT has a tendency to form blood vessels that lack normal capillaries between an artery and vein. This means that in a person with HHT, arterial blood under high pressure flows directly into a low pressure vein without first having to squeeze through the many very small capillaries. This place where an artery is connected directly to a vein tends to be a fragile site that can rupture and bleed. Additionally, since the capillaries did not form correctly, they are not able to deliver oxygen to tissues as effectively.

Normal Capillary Bed

Abnormal Capillary Bed from HHT

Normal Blood Vessel Formation
Abnormal Capillary Bed

What causes HHT?

HHT is caused by a change (called a variation or mutation) in one of several HHT-associated genes.

Having a mutation in an HHT gene causes blood vessels to form improperly, leading to the symptoms of HHT. Mutations in the ENG and ACVRL-1 (or ALK-1) genes account for 80% of all cases of HHT. There are at least two other genes that have not yet been identified that also appear to cause HHT symptoms in a smaller number of individuals.

Endoglin (ENG)

A mutation in the ENG gene causes HHT1. Lung and brain AVMs are more common in patients with HHT1.

Activin Receptor-like Kinase 1 (ACVRL1 or ALK1)

A mutation in ALK1 causes HHT2. Liver AVMs are more common in people with HHT2.

SMAD-related Protein 4 (SMAD4)

3-5% of cases of HHT are caused by a mutation in the SMAD4 gene. A mutation in SMAD4 causes a combined syndrome of juvenile polyps of the GI tract and HHT, also known as JP-HHT.

The chance of a child inheriting the HHT gene mutation from a parent with HHT:


How is HHT inherited?

One possible configuration of a family of five, where one parent has HHT. Each of the three children had a 50% chance of inheriting the HHT gene mutation. In this case, only one of the three children inherited HHT.

Above: One possible configuration of a family of five, where one parent has HHT. For each of the three children, there was a 50% chance of inheriting the HHT gene mutation. In this case, only one of the three children inherited HHT. Gender does not affect whether someone will inherit the disease.

HHT is an autosomal dominant genetic disorder. This means that if a parent has HHT, no matter their gender, each of their children will have a 50% chance of having HHT.

Every person has two copies of each gene, one copy from their mother and one from their father. A person with HHT has one mutated copy of an HHT-associated gene and one normal copy, the mutated copy causes their HHT. When a person with HHT has a child, he or she will either pass on the normal copy of the gene or the copy with the HHT-causing mutation. A child who inherits the HHT gene with the mutation will have HHT, while if a child inherits the normal copy of the HHT gene, they will not have HHT. Therefore, each time an HHT affected person has a child, there is a 50% (1 in 2) chance that the child will have HHT.

Nearly everyone with HHT will have inherited the disorder from a parent who also has HHT. In very rare cases, a change in an HHT gene occurs in the egg or sperm cell of someone who does not have HHT themselves. In these cases, the resulting child will have HHT, even though the parents do not.

HHT does not discriminate.

It affects males and females of all ages and ethnic groups.

1 in 5,000 people have HHT worldwide.

There are 70,000 HHT patients in the U.S.


How is HHT diagnosed?

A person can be diagnosed with HHT through either a clinical examination, genetic testing, or both.

The Curacao Criteria are used to diagnose HHT through clinical evaluation by a physician. Briefly, they are:

  1. Nosebleeds
  2. Telangiectasia
  3. AVMs
  4. Family History of HHT

Someone definitely has HHT is they have 3 or more of the above criteria. Someone possibly has HHT if they have 2 of the criteria. Finally, someone is unlikely to have HHT if they have less than two of the criteria.

What are the screening guidelines for someone with HHT?

There are different screening guidelines for adults, pregnant people, and children. Anyone diagnosed or thought to have HHT should be screened for:

  • Anemia
  • Cerebral VMs (or brain VM)
  • Pulmonary AVMs
  • Liver AVMs
  • GI Telangiectasias

Can HHT be treated?

Yes! Although there is not yet a way to prevent telangiectasia or AVMs from forming, most can be treated once they occur. They should be treated if they are causing a significant problem (as in the case of frequent nosebleeds) or if they have a high risk of causing a problem (such as a stroke from a Pulmonary AVM or brain VM). The current recommended treatment for telangiectasia or AVM depends on both the size and location in the body.

There are 40 HHT Centers of Excellence in North America and over 60 worldwide, where patients can receive comprehensive, expert HHT care.

Learn More

Signs & Symptoms

HHT is more than a nosebleed


Commonly asked HHT questions

HHT Treatment Centers

Over 60 worldwide

Scroll To Top